These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2822176

  • 1. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura.
    Murphy WG, Moore JC, Kelton JG.
    Blood; 1987 Nov; 70(5):1683-7. PubMed ID: 2822176
    [Abstract] [Full Text] [Related]

  • 2. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC, Murphy WG, Kelton JG.
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [Abstract] [Full Text] [Related]

  • 3. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles.
    Kelton JG, Warkentin TE, Hayward CP, Murphy WG, Moore JC.
    Blood; 1992 Nov 01; 80(9):2246-51. PubMed ID: 1421394
    [Abstract] [Full Text] [Related]

  • 4. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
    Kelton JG, Moore JC, Murphy WG.
    Blood; 1987 Mar 01; 69(3):924-8. PubMed ID: 3493046
    [Abstract] [Full Text] [Related]

  • 5. A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura.
    Falanga A, Consonni R, Ruggenenti P, Barbui T.
    Br J Haematol; 1991 Nov 01; 79(3):474-80. PubMed ID: 1751375
    [Abstract] [Full Text] [Related]

  • 6. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M, Lämmle B.
    Best Pract Res Clin Haematol; 2001 Jun 01; 14(2):437-54. PubMed ID: 11686108
    [Abstract] [Full Text] [Related]

  • 7. Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura.
    Zeigler ZR, Kelton JG, Moore JC, Shadduck RK, Andrews DF, Nath R, Agha M.
    Bone Marrow Transplant; 1999 Sep 01; 24(6):641-5. PubMed ID: 10490730
    [Abstract] [Full Text] [Related]

  • 8. Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura.
    Kelton JG, Moore JC, Warkentin TE, Hayward CP.
    Br J Haematol; 1996 May 01; 93(2):421-6. PubMed ID: 8639442
    [Abstract] [Full Text] [Related]

  • 9. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL, McPherson PD.
    Am J Med; 1989 Sep 01; 87(3N):9N-15N. PubMed ID: 2486537
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura.
    Chow TW, Turner NA, Chintagumpala M, McPherson PD, Nolasco LH, Rice L, Hellums JD, Moake JL.
    Am J Hematol; 1998 Apr 01; 57(4):293-302. PubMed ID: 9544973
    [Abstract] [Full Text] [Related]

  • 13. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells.
    Burns ER, Zucker-Franklin D.
    Blood; 1982 Oct 01; 60(4):1030-7. PubMed ID: 7052160
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
    Tsai HM, Rice L, Sarode R, Chow TW, Moake JL.
    Ann Intern Med; 2000 May 16; 132(10):794-9. PubMed ID: 10819702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN, Zhou FX, Bradford H, Hu CJ, Colman RF, Colman RW.
    Arch Biochem Biophys; 1989 Jun 16; 271(2):346-58. PubMed ID: 2543293
    [Abstract] [Full Text] [Related]

  • 18. Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.
    Consonni R, Falanga A, Barbui T.
    Br J Haematol; 1994 Jun 16; 87(2):321-4. PubMed ID: 7947274
    [Abstract] [Full Text] [Related]

  • 19. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo.
    Mayr FB, Knöbl P, Jilma B, Siller-Matula JM, Wagner PG, Schaub RG, Gilbert JC, Jilma-Stohlawetz P.
    Transfusion; 2010 May 16; 50(5):1079-87. PubMed ID: 20070617
    [Abstract] [Full Text] [Related]

  • 20. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
    Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B.
    Blood; 1997 May 01; 89(9):3097-103. PubMed ID: 9129011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.